Stock repurchase programs are often seen as a sign of confidence in a company's future growth prospects. By repurchasing its own shares, Atossa Therapeutics is signaling that it believes its stock is undervalued and that its future performance will justify a higher valuation. This may lead to increased investor confidence and a potential short-term increase in the stock price.